Lynch syndrome (LS) is an autosomal dominant cancer predisposition syndrome caused by a pathogenic germline variant of one of the DNA mismatch repair (MMR) genes (MLH1, MSH2, MSH6, or PMS2) or epigenetic silencing of MSH2 caused by a deletion in the EPCAM gene1,2. The gene discussed is PMS2; the disease is Leigh syndrome.